SANRECO is a clinical study testing an experimental treatment -divesiran

SANRECO is a clinical study testing an experimental treatment – divesiran (also referred to as SLN124). The aim of the study is to learn the effects of this treatment in people living with Polycythemia Vera (PV). We are currently recruiting for the Phase 2 part of the study.

If you are interested in receiving more information about this clinical study, please complete the form below.

First Name(Required)
Family Name(Required)
Country(Required)
Consent(Required)
This field is for validation purposes and should be left unchanged.